CODEX+ CELIDA Recommendations
1.5.2 - ci-build
CODEX+ CELIDA Recommendations - Local Development build (v1.5.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Active as of 2022-02-14 |
<PlanDefinition xmlns="http://hl7.org/fhir">
<id value="RecCollectionProphAnticoagulationHospitalizedCOVID19Patients"/>
<meta>
<profile
value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: PlanDefinition RecCollectionProphAnticoagulationHospitalizedCOVID19Patients</b></p><a name="RecCollectionProphAnticoagulationHospitalizedCOVID19Patients"> </a><a name="hcRecCollectionProphAnticoagulationHospitalizedCOVID19Patients"> </a><a name="RecCollectionProphAnticoagulationHospitalizedCOVID19Patients-en-US"> </a><p><b>url</b>: <a href="PlanDefinition-RecCollectionProphAnticoagulationHospitalizedCOVID19Patients.html">PlanDefinition Prophylactic anticoagulation in hospitalized COVID-19 patients</a></p><p><b>version</b>: 1.0</p><p><b>name</b>: 15 - Prophylactic Anticoagulation</p><p><b>title</b>: Prophylactic anticoagulation in hospitalized COVID-19 patients</p><p><b>type</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type workflow-definition}">Workflow Definition</span></p><p><b>status</b>: Active</p><p><b>experimental</b>: true</p><p><b>date</b>: 2022-02-14</p><p><b>publisher</b>: Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin e.V. (DGIIN)</p><p><b>description</b>: </p><div><p>Hospitalisierte Patienten mit COVID-19 sollen in Abwesenheit von Kontraindikationen eine standardmäßige medikamentöse Thromboembolieprophylaxe mit niedermolekularem Heparin erhalten. Alternativ kann Fondaparinux zur Anwendung kommen.</p>
</div><blockquote><p><b>action</b></p><p><b>title</b>: AntithromboticProphylaxisWithLWMH</p><p><b>description</b>: </p><div><p>Antithrombotic prophylaxis with LWMH in hospitalised COVID-19 patients</p>
</div><p><b>code</b>: <span title="Codes:{http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process guideline-based-care}">Guideline-based Care</span></p><p><b>definition</b>: <a href="PlanDefinition-AntithrombLWMHProphInHospitalisedCOVID19PatientsRecommPlan.html">Antithrombotic prophylaxis with LWMH in hospitalised COVID-19 patients</a></p></blockquote><blockquote><p><b>action</b></p><p><b>title</b>: AntithromboticProphylaxisWithFondaparinux</p><p><b>description</b>: </p><div><p>Antithrombotic prophylaxis with Fondaparinux</p>
</div><p><b>code</b>: <span title="Codes:{http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process guideline-based-care}">Guideline-based Care</span></p><p><b>definition</b>: <a href="PlanDefinition-AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan.html">Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients</a></p></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability">
<valueCode value="computable"/>
</extension>
<extension
url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel">
<valueCode value="structured"/>
</extension>
<extension
url="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/ext-action-combination-method">
<extension url="method">
<valueCodeableConcept>
<coding>
<system
value="https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method"/>
<code value="exactly"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="threshold">
<valuePositiveInt value="1"/>
</extension>
</extension>
<url
value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/prophylactic-anticoagulation"/>
<version value="1.0"/>
<name value="15 - Prophylactic Anticoagulation"/>
<title
value="Prophylactic anticoagulation in hospitalized COVID-19 patients"/>
<type>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
<code value="workflow-definition"/>
</coding>
</type>
<status value="active"/>
<experimental value="true"/>
<date value="2022-02-14"/>
<publisher
value="Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin e.V. (DGIIN)"/>
<description
value="Hospitalisierte Patienten mit COVID-19 sollen in Abwesenheit von Kontraindikationen eine standardmäßige medikamentöse Thromboembolieprophylaxe mit niedermolekularem Heparin erhalten. Alternativ kann Fondaparinux zur Anwendung kommen."/>
<action>
<title value="AntithromboticProphylaxisWithLWMH"/>
<description
value="Antithrombotic prophylaxis with LWMH in hospitalised COVID-19 patients"/>
<code>
<coding>
<system
value="http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process"/>
<code value="guideline-based-care"/>
</coding>
</code>
<definitionCanonical
value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/antithrombotic-prophylaxis-LMWH"/>
</action>
<action>
<title value="AntithromboticProphylaxisWithFondaparinux"/>
<description value="Antithrombotic prophylaxis with Fondaparinux"/>
<code>
<coding>
<system
value="http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process"/>
<code value="guideline-based-care"/>
</coding>
</code>
<definitionCanonical
value="https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/antithrombotic-prophylaxis-fondaparinux"/>
</action>
</PlanDefinition>